期刊文献+

Cav1.1基因26内含子67位点A/G多态性与甲状腺功能亢进性周期性瘫痪的相关性研究 被引量:2

Association between calcium channel α1 subunit gene and thyrotoxic periodic paralysis
原文传递
导出
摘要 目的探讨钙通道α1亚基(Cav1.1)基因26内含子-67A/G多态性与男性甲状腺功能亢进(简称甲亢)性周期性瘫痪(TPP)的相关性。方法采用多聚酶链反应单链构象多态性(PCR SSCP)方法检测46例男性TPP患者(TPP组)、68例男性甲亢患者(GD组)和72名男性健康对照者(CON组)Cav1.1基因26内含子-67A/G多态性。分析比较此多态位点基因型和等位基因在不同人群中分布的差异。结果(1)TPP组、GD组及CON组AG+GG基因型频率分别为47.83%、14.71%、29.17%,G等位基因频率分别为44.57%、13.24%、27.78%。(2)TPP组AG+GG基因型频率明显高于GD组和CON组(OR=5.32,P<0.01;OR=2.23,P=0.04),TPP组G等位基因频率明显高于GD组和CON组(OR=5.27,P<0.01;OR=2.09,P=0.008)。结论Cav1.1基因26内含子-67位点A/G多态性与男性TPP有相关性。 Objective To explore the relationship between calcium channel α1 subunit ( Cav1. 1 ) gene intron 26 -67 A/G polymorphism and thyrotoxic periodic paralysis(TPP). Methods Cav1. 1 gene polymorphism at position -67 was determined by polymerase chain reaction-single-strand conformation polymorphism (PCR-SSCP) in 46 male patients with TPP, 68 male Graves' disease (GD) patients without TPP and 72 healthy male controls. The difference of genotype and the variation of allele frequencies were analyzed by Chi-square test. Results ( 1 ) Frequencies distribution of AG + GG genotype in TPP, GD and control groups were 47.83% , 14.71% and 29. 17% respectively, and those of allele G were 44. 57% , 13.24% and 27. 78% for the three groups respectively. (2) Frequencies of -67 AG + GG genotype in TPP group were significantly higher than those in GD and CON group ( OR = 5.32, P 〈 0. 01 ; OR = 2.23, P = 0. 04). Frequencies of allele G in TPP group were significantly higher than those in GD and CON group (OR=5.27, P〈0.01; 0R=2.09, P=0.008). Conclusion Allele G of Cav1. 1 gene at position -67 may be associated with TPP in male HAN population.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2006年第6期396-398,共3页 Chinese Journal of Neurology
关键词 低钾性周期性麻痹 甲状腺功能亢进症 钙通道 多态现象(遗传学) Hypokalemic periodic paralysis Hyperthyroidism Calcium channels Polymorphism (genetics)
  • 相关文献

参考文献12

  • 1Liu YC,Tsai WS,Chau T,et al.Acute hypercapnic respiratory failure due to thyrotoxic periodic paralysis.Am J Med Sci,2004,327:264-267.
  • 2Tassone H,Moulin A,Henderson SO.The pitfalls of potassium replacement in thyrotoxic periodic paralysis:a case report and review of the literature.J Emerg Med,2004,26:157-161.
  • 3Akar S,Comlekci A,Birlik M,et al.Thyrotoxic periodic paralysis in a Turkish male:the recurrence of the attack after radioiodine treament.Endocr J,2005,52:149-151.
  • 4袁梦华,谷奕,康东红,李梅,邱明才.Graves病甲亢低血钾倾向的临床研究[J].天津医药,2004,32(7):403-405. 被引量:5
  • 5Ferreiro JE,Arguelles DJ,Rams H Jr.Thyrotoxic periodic paralysis.Am J Med,1986,80:146-150.
  • 6Benatar M.Neurological potassium channelopathies.QJM,2000,93:787-797.
  • 7王卫庆,姜蕾,朱娜,叶蕾,苏颋为,俞放,赵咏桔,李小英,宁光.中国人低血钾性周期性麻痹家系:SCN4A新突变位点[J].中华内分泌代谢杂志,2004,20(6):523-526. 被引量:17
  • 8Kim SH,Kim UK,Chae JJ,et al.Identification of mutations including de novo mutations in Korean patients with hypokalaemic periodic paralysis.Nephrol Dial Transplant,2001,16:939-944.
  • 9Chen L,Lang D,Ran XW,et al.Clinical and molecular analysis of Chinese patients with thyrotoxic periodic paralysis.Eur Neurol,2003,49:227-230.
  • 10Ng WY,Lui KF,Thai AC,et al.Absence of ion channels CACN1AS and SCN4A mutations in thyrotoxic hypokalemic periodic paralysis.Thyroid,2004,14:187-190.

二级参考文献15

  • 1陈灏珠.实用内科学(第11版)[M].北京:人民卫生出版社,2001.1785.
  • 2Polderman KH, Peerdeman SM, Girbes AIR. Hypophosphatemia and hypomagnesemia induced by cooling in patients with severe head injury. J Neurosurg, 2001,94 : 853 - 858.
  • 3Poza J J, Lopez de Munain A, Garcia-Bragado F, et al. Andersen syndrome. Description of a case. Neurologia, 2000, 15:366- 369.
  • 4尹芳 赵录年 董德长.甲亢并发远端肾小管酸中毒2例报告[J].中华肾脏病杂志,1989,5(2):106-106.
  • 5Ptacek LJ, Tawil R, Griggs RC, et al. Dihydropyridine receptor mutations cause hypokalemic periodic paralysis. Cell, 1994,77: 863-868.
  • 6Jurkat-Rott K, Lehmann-Horn F, Elbaz A, et al. A calcium channel mutation causing hypokalemic periodic paralysis. Hum Mol Genet,1994,3:1415-1419.
  • 7Elbaz A, Vale-Santos J, Jurkat-Rott K, et al. Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families. Am J Hum Genet, 1995,56:374-380.
  • 8Plaasart E, Elbaz A, Santos JV, et al. Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP). Hum Genet, 1994,94:551-556.
  • 9Bulman DE, Scoggan KA, van Oene MD, et al. A novel sodium channel mutation in a family with hypokalemic periodic paralysis. Neurology,1999,53:1932-1936.
  • 10Jurkat-Rott K, Mitrovic N, Hang C, et al. Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current. Proc Natl Acad Sci U S A,2000,97 :9549 -9554.

共引文献20

同被引文献36

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部